Date published: 2026-1-9

1-800-457-3801

SCBT Portrait Logo
Seach Input

H-Ras Inhibitors

H-Ras inhibitors belong to a distinct chemical class of compounds designed to specifically target and interact with the H-Ras protein, which is a member of the Ras family of small GTPases. These inhibitors are characterized by their ability to obstruct the activity of H-Ras by interfering with its function as a molecular switch, which plays a crucial role in various cellular signaling pathways. H-Ras, like other Ras proteins, is involved in the regulation of cell growth, proliferation, and differentiation. When activated, it transmits signals from cell surface receptors to the intracellular machinery, influencing important cellular processes. However, aberrant activation of H-Ras has been implicated in the development and progression of several diseases, particularly cancer. H-Ras inhibitors work by binding to specific regions on the H-Ras protein, often the active site or allosteric sites, preventing it from switching between its active (GTP-bound) and inactive (GDP-bound) states. By interfering with this dynamic process, H-Ras inhibitors hinder the transmission of signals downstream, ultimately leading to the disruption of cellular pathways that rely on H-Ras activity. Consequently, this inhibition may help restore normal cellular function and control aberrant cell growth. Chemically, H-Ras inhibitors can vary widely, and multiple structural scaffolds have been explored to achieve effective inhibition.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Tipifarnib

192185-72-1sc-364637
10 mg
$720.00
(0)

Tipifarnib is a farnesyltransferase inhibitor (FTI) that blocks the farnesylation of H-ras and other Ras proteins. This modification is essential for their proper functioning, and by inhibiting it, Tipifarnib disrupts Ras signaling pathways, potentially leading to antitumor effects.

Lonafarnib

193275-84-2sc-482730
sc-482730A
5 mg
10 mg
$173.00
$234.00
(0)

Lonafarnib is a farnesyltransferase inhibitor that has shown promise in inhibiting H-ras and other Ras proteins. It has been investigated for its potential anticancer effects, particularly in certain types of tumors that are driven by Ras mutations.

Manumycin A

52665-74-4sc-200857
sc-200857A
1 mg
5 mg
$219.00
$634.00
5
(1)

Manumycin A is an antibiotic that also inhibits farnesyltransferase. As a result, it can disrupt the proper localization and activity of H-ras and other Ras proteins, potentially impacting tumor growth and proliferation.

2-hydroxybenzaldehyde semicarbazone

3030-97-5sc-274882
1 g
$524.00
(0)

This compound is known to inhibit H-ras prenylation and could potentially be explored as an anticancer agent by disrupting Ras signaling.

Sulindac

38194-50-2sc-202823
sc-202823A
sc-202823B
1 g
5 g
10 g
$32.00
$86.00
$150.00
3
(1)

Sulindac is a nonsteroidal anti-inflammatory drug (NSAID) that has been investigated for its potential inhibitory effects on H-ras. It may act by interfering with Ras signaling pathways, but its exact mechanism of action is not fully understood.